RedHill Biopharma RDHL
NASDAQ RDHL
$0.46 -0.05 (-10.31%)
As of: Oct 21, 2026 · 3:45 PM EDT

RedHill Biopharma (RDHL) Non-cash Items (2017 - 2022)

Updated

RedHill Biopharma's Non-cash Items came in at -$7.25 million for the year ended Dec 31, 2025, compared with -$3.15 million a year earlier.

Analysis

RedHill Biopharma (RDHL) Non-cash Items (2017 - 2022) Analysis & Trends

Going back to the year ended Dec 31, 2015, RedHill Biopharma's Non-cash Items data covers 11 years.

  • The five-year range for annual Non-cash Items is -$44.12 million (the year ended Dec 31, 2023) to $34.48 million (the year ended Dec 31, 2022).
  • Per Business Quant, earlier years put Non-cash Items at -$3.15 million in the year ended Dec 31, 2024, -$44.12 million in the year ended Dec 31, 2023, $34.48 million in the year ended Dec 31, 2022 (+1.8%) and $33.85 million in the year ended Dec 31, 2021 (+76.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 RedHill Biopharma 1.44 Mn -15.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 510,000.00
Jun 30, 2021 8.80 Mn
Jun 30, 2020 4.28 Mn
Jun 30, 2019 -224,000.00
Jun 30, 2018 2.48 Mn
Jun 30, 2017 -1.67 Mn
API Access

RedHill Biopharma Non-cash Items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-cash-items&ticker=RDHL&period=max&api_key=YOUR_API_KEY